Overview

A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-1

Status:
Completed

Trial end date:
2009-03-01

Target enrollment:

Participant gender:

Summary

A multicenter study to evaluate the safety and efficacy of ezetimibe/simvastatin versus atorvastatin in elderly patients with high cholesterol at high or moderately high risk for coronary heart disease.

Phase:

Phase 3

Details

Lead Sponsor:

Merck Sharp & Dohme Corp.

Collaborator:

Merck Shering-Plough JV Study

Treatments:

Atorvastatin
Atorvastatin Calcium
Ezetimibe
Ezetimibe, Simvastatin Drug Combination
Simvastatin